Calculated plasma volume status predicts outcomes after transcatheter aortic valve implantation
Open Access
- 23 December 2020
- journal article
- research article
- Published by BMJ in Open Heart
- Vol. 7 (2), e001477
- https://doi.org/10.1136/openhrt-2020-001477
Abstract
Objectives Congestion can worsen outcomes after transcatheter aortic valve implantation (TAVI), but can be difficult to quantify non-invasively. We hypothesised that preprocedural plasma volume status (PVS), estimated using a validated formula that enumerates percentage change from ideal PV, would provide prognostic utility post-TAVI. Methods This retrospective cohort study identified patients who underwent TAVI (2007–2017) from a prospectively collected database. Actual ([1-haematocrit] × [a + (b × weight (Kg))] and ideal (c × weight (Kg)) PV were quantified from equations where a, b and c are sex-dependent constants. Calculated PVS was then derived (100% x [(actual – ideal PV)/ideal PV]). Results In 564 patients (mean age 82±7 years, 49% male), mean PVS was −2.7±10.2%, with PV expansion (PVS >0%) evident in 39%. Only logistic European System for Cardiac Operative Risk Evaluation (EuroSCORE) independently predicted a PVS >0% (OR 1.85, p=0.002). On Cox analyses, a PVS >0% was associated with greater mortality at 3 (HR 2.29, 95% CI 1.11 to 4.74, p=0.03) and 12 months (HR 2.00, 95% CI 1.23 to 3.26, p=0.006) after TAVI, independently of, and incremental to, the EuroSCORE and New York Heart Association class. A PVS >0% was also independently associated with more days in intensive care (coefficient: 0.41, 95% CI 0.04 to 0.78, p=0.03) and in hospital (coefficient: 1.95, 95% CI 0.48 to 3.41, p=0.009). Conclusion Higher PVS values, calculated simply from weight and haematocrit, are associated with greater mortality and longer hospitalisation post-TAVI. PVS could help refine risk stratification and further investigations into the utility of PVS-guided management in TAVI patients is warranted.Keywords
This publication has 21 references indexed in Scilit:
- 2016 Annual Report of The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy RegistryJournal of the American College of Cardiology, 2016
- Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk PatientsThe New England Journal of Medicine, 2016
- Effect of Gender After Transcatheter Aortic Valve Implantation: A Meta-AnalysisThe Annals of Thoracic Surgery, 2015
- Calculated plasma volume status and prognosis in chronic heart failureEuropean Journal of Heart Failure, 2014
- Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trialEuropean Heart Journal, 2013
- Updated Standardized Endpoint Definitions for Transcatheter Aortic Valve ImplantationJournal of the American College of Cardiology, 2012
- Relation of unrecognized hypervolemia in chronic heart failure to clinical status, hemodynamics, and patient outcomesThe American Journal of Cardiology, 2004
- Pathophysiology and clinical implications of perioperative fluid excessBritish Journal of Anaesthesia, 2002
- The Limited Reliability of Physical Signs for Estimating Hemodynamics in Chronic Heart FailureJAMA, 1989